ARCEDI Biotech Developing Cystic Fibrosis, Cancer Tests; Plans to Expand NIPT Offering
The Danish rare cell diagnostics company is also in the process of migrating its tests from array comparative hybridization to next-generation sequencing.
United States Ripudaman Singh Karina Dalsgaard Dahl Jeppesen Agilent Technologies World Congress On Controversies
Source: genomeweb.com